Biogen (BIIB) Minority Interest (2016 - 2023)
Historic Minority Interest for Biogen (BIIB) over the last 15 years, with Q3 2023 value amounting to -$4.1 million.
- Biogen's Minority Interest rose 5287.36% to -$4.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$4.1 million, marking a year-over-year increase of 5287.36%. This contributed to the annual value of -$9.5 million for FY2022, which is 11496.06% down from last year.
- According to the latest figures from Q3 2023, Biogen's Minority Interest is -$4.1 million, which was up 5287.36% from -$6.4 million recorded in Q2 2023.
- Biogen's 5-year Minority Interest high stood at $462.9 million for Q2 2021, and its period low was -$21.6 million during Q1 2022.
- In the last 5 years, Biogen's Minority Interest had a median value of -$8.7 million in 2022 and averaged $42.8 million.
- Its Minority Interest has fluctuated over the past 5 years, first crashed by 37560.98% in 2020, then skyrocketed by 332714.29% in 2021.
- Over the past 5 years, Biogen's Minority Interest (Quarter) stood at -$4.1 million in 2019, then tumbled by 246.34% to -$14.2 million in 2020, then skyrocketed by 547.18% to $63.5 million in 2021, then plummeted by 114.96% to -$9.5 million in 2022, then soared by 56.84% to -$4.1 million in 2023.
- Its last three reported values are -$4.1 million in Q3 2023, -$6.4 million for Q2 2023, and -$9.6 million during Q1 2023.